Telomerase activity in periampullary tumors correlates with aggressive malignancy

Annals of Surgery

Volumn 234, Issue 3, 2001, Pages 344-351

  Balcom IV, James H ^a   Keck, Tobias ^a   Warshaw, Andrew L ^a   Antoniu, Bozena ^a   Graeme Cook, Fiona ^a   Fernández del Castillo, Carlos ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

CANCER INVASION; CANCER STAGING; CATALYSIS; CONFERENCE PAPER; ENZYME ACTIVITY; HUMAN; LYMPH NODE METASTASIS; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; PANCREAS TUMOR; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; AMPULLA OF VATER; CARCINOMA, PAPILLARY; CHOLANGIOCARCINOMA; DUODENAL NEOPLASMS; FLUOROMETRY; HUMANS; LYMPHATIC METASTASIS; PANCREATIC NEOPLASMS; PANCREATITIS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0034849503     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200109000-00008     Document Type: Conference Paper

References (49)

1. Structure and function of telomeres
2. Telomeres shorten during ageing of human fibroblasts
3. Telomere length predicts replicative capacity of human fibroblasts
4. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes
5. Telomere positional effects and the regulation of cellular senescence
6. Telomere loss: Mitotic clock or genetic time bomb?
7. Specific association of human telomerase activity with immortal cells and cancer
8. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats
9. Telomeres, telomerase, immortality
10. Telomerase activity in normal and malignant mammalian tissues: Feasibility of telomerase as a target for cancer chemotherapy
11. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis
12. Creation of human tumour cells with defined genetic elements
13. Quantification of telomerase activity in sporadic colorectal carcinoma: Association with tumor growth and venous invasion
14. Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer
15. Prognostic impact of telomerase activity in non-small cell lung cancers
16. Pancreatic carcinoma
17. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s
18. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma
19. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization
20. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation
21. c-Ki-ras point mutations in ductectatic-type mucinous cystic neoplasms of the pancreas
22. p53 mutations in pancreatic carcinoma and evidence of common involvement in homopolymer tracts in DNA microdeletions
23. The detection of telomerase activity in patients with adenocarcinoma of the pancreas by fine-needle aspiration
24. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: Comparison with K-ras mutations
25. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states
26. Telomerase activity for the preoperative diagnosis of pancreatic cancer
27. Telomerase activity is detected in pancreatic cancer but not in benign tumors
28. Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers
29. Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity
30. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts
31. Embryonic stem cell lines derived from human blastocysts
32. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
33. Detection of telomerase activity utilizing energy transfer primers: Comparison with gel- and ELISA-based detection
34. Telomerase activity in ductal carcinoma in situ and invasive breast cancer
35. High telomerase activity in primary lung cancers: Association with increased cell proliferation rates and advanced pathologic stage
36. Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis
37. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium
38. Correlation of the expression of human telomerase subunits with telomerase activity in normal skin and skin tumors
39. Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples
40. Expression of human telomerase subunit genes in primary lung cancer and its clinical significance
41. Long-term survival following pancreaticoduodenectomy for adenocarcinoma of the head of the pancreas
42. Factors influencing survival after resection for ductal adenocarcinoma of the pancreas
43. Prognostic indicators for survival after resection of pancreatic adenocarcinoma
44. Precancerous conditions of pancreatic carcinoma
45. Progression of pancreatic intraductal neoplasia to infiltrating adenocarcinoma of the pancreas
46. Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions
47. Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma
48. Immortalized mouse mammary cells in vivo do not exhibit increased telomerase activity
49. For better or worse? Telomerase inhibition and cancer